
GC32741
CCT-251921
Also known as 8-[2-amino-3-chloro-5-(1-methylindazol-5-yl)-4-pyridinyl]-2,8-diazaspiro[4.5]decan-1-one
CCT-251921 is a potent, selective, and orally bioavailable CDK8 inhibitor with an IC50 of 2·3 nM
ChemicalCAS1607837-31-9MW410.9FormulaC21H23ClN6O
- CAS number
- 1607837-31-9
- Molecular weight
- 410.9
- Formula
- C21H23ClN6O
- Solubility
- DMSO : ≥ 28 mg/mL (68·14 mM)
- InChIKey
- VPJXPDLMACOGIZ-UHFFFAOYSA-N
- Catalogue number
- GC32741
- Brand
- GLPBIO
Computed properties PubChem CID 74222277 · XLogP 2.3 · TPSA 89.1 Ų · H-bond donors 2
- XLogP
- 2.3
- TPSA
- 89.1 Ų
- H-bond donors
- 2
- H-bond acceptors
- 5
- Rotatable bonds
- 2
- Heavy atoms
- 29
SMILES CN1C2=C(C=C(C=C2)C3=CN=C(C(=C3N4CCC5(CCNC5=O)CC4)Cl)N)C=N1
Computed descriptors from PubChem (CID 74222277), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il